Richard Greil

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

Michael R. Bishop, Michael Dickinson, Duncan Purtill et al. · New England Journal of Medicine · 2021 · 491 citations · Full text

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Catherine Thiéblemont, Hervé Tilly, María Gomes da Silva et al. · Journal of Clinical Oncology · 2017 · 189 citations

Elderly Patients, Immunology, Pathology +16

Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination

Francisco J. Rivera, Alerie Guzman de la Fuente, Chao Zhao et al. · Glia · 2019 · 33 citations · Full text

Regenerative Medicine, Mesenchymal Stem Cells, Neuroregeneration +15

Intravascular large B-cell lymphoma with a fulminant clinical course: a case report with definite diagnosis post mortem

Michael Fiegl, Richard Greil, C. Pechlaner et al. · Annals of Oncology · 2002 · 29 citations · Full text

Lymphoid Neoplasia, Surgical Pathology, Fulminant Clinical Course +2

Performance Characteristics of the Cobas Ampliprep/Cobas Taqman V2.0 and the Abbott Realtime Hepatitis C Assays - Implications for Response-Guided Therapy in Genotype 1 Infections

Ninon Taylor, Elisabeth Haschke‐Becher, Richard Greil et al. · Antiviral Therapy · 2013 · 14 citations · Full text